N+1 Singer reaffirmed their corporate rating on shares of Instem PLC (LON:INS) in a research report sent to investors on Monday morning.

Shares of Instem PLC (LON:INS) opened at 295.00 on Monday. The stock’s 50 day moving average is GBX 254.12 and its 200 day moving average is GBX 234.72. The stock’s market capitalization is GBX 38.48 million. Instem PLC has a 1-year low of GBX 185.00 and a 1-year high of GBX 300.00.

Instem PLC Company Profile

Instem plc is a supplier of information technology (IT) applications to the early development healthcare market delivering solutions for data collection, management and analysis across the research and development continuum. The Company is engaged in Global Life Sciences operations. Its lead product suite, Provantis, is an application in the Early Development Safety Assessment (EDSA) market.

Receive News & Ratings for Instem PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Instem PLC and related companies with MarketBeat.com's FREE daily email newsletter.